A Forward View
Its been a busy month for change and guidance; the remainder of September does not look different. Change is what we need to learn to live with for the remainder of 2020.
We share with you this parliamentary question (PQ) from 09 September 2020 – on access to OTC medicines post-EU Exit, written by Layla Moran, Liberal Democrat MP for Oxford West and Abingdon, on post-EU Exit access to OTC medicines.
To ask the Secretary of State for Health and Social Care, what steps his Department is taking to ensure that the public have uninterrupted access to over the counter medicines in the event of the UK leaving the EU without a deal.
In response, Minister of State, Edward Argar stated: “The Department, in consultation with the devolved administrations and Crown Dependencies, is working with trade bodies, product suppliers, and the health and care system in England to make detailed plans to help ensure continued supply of medicines and medical products, including medical radioisotopes and over-the-counter medicines, to the whole of the United Kingdom at the end of the transition period in all scenarios. The Department understands that a flexible approach to preparedness may be required for medicines that cannot be stockpiled, such as some medical radioisotopes. We have asked suppliers of those products to use airfreight, which some suppliers are already doing now. Further detail on the plans to help ensure continuity of medical supplies has been communicated to suppliers”
Further detail via this link.
This makes clear that there is a possibility of an interrupted supply of OTC medicines or a potential increase in costs to receive them. Suppliers and distributors will be looking to ensure this does not happen. One positive step to take as the year draws to close, is to plan ahead for 2021. At this time of year budgets are requested, challenged and new project planning can begin. OTC Experts can help you unlock the potential of your products and ideas. Contact us on firstname.lastname@example.org